David M. DeBauche, PhD, FFACMG, was named the new cytogenetics laboratory manager at Molecular Pathology Laboratory Network, Inc. (MPLN).
Dr. DeBauche joins the technical and scientific staff at MPLN with more than 20 years experience in cytogenetics and medical genetics.
Board certified in clinical cytogenetics, Dr. DeBauche earned a bachelor’s degree in biology from St. Norbert College in DePere, Wisconsin, where he graduated cum laude.
He also earned his PhD in biochemistry from Marquette University in Milwaukee and completed a fellowship in clinical cytogeneitcs in the Department of Pathology and Laboratory Medicine at the Medical University of South Carolina (MUSC) as well as a fellowship in medical genetics in the Department of Pediatrics in MUSC.
Prior to joining MPLN, Dr. DeBauche held the positions of director and technical director at Genzyme Genetics for more than 11 years in Santa Fe, NM and Tampa, Fl. He also served as the department head of cytogenetics at T.C. Thompson Children’s Hospital in Chattanooga. Dr. DeBauche was also a clinical cytogeneticist and a PhD Medical Geneticist at University of Mississippi Medical Center in Jackson, MS.
Dr. DeBauche is a Founding Fellow of the American College of Medical Genetics and an inspector with the CAP Laboratory Accreditation Program. He is also a member of the American Society of Human Genetics, the Southeast Regional Genetics Group and the Pediatric Oncology Group.
MPLN is a privately held molecular diagnostic laboratory founded in 1989 and headquartered in Maryville, Tenn. A leader in laboratory medicine, MPLN offers a comprehensive selection of molecular diagnostics and cytogenetic testing that targets oncology, women’s health, prenatal care, medical genetics and pharmacogenetics and infectious disease.
The laboratory also has extensive expertise in chromosome analysis, flow cytometry, fluorescence in situ hybridization (FISH), real-time and quantitative polymerase chain reaction technologies, immunohistochemistry and gene sequencing.
For more information about MPLN’s advanced technologies and personalized services, call 800-932-2943 or visit www.mplnet.com.